Cardlytics, Inc. — Form 8-K
Filed August 5, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 62/100
What the filing says
Cardlytics reported Q2 2026 revenue of $36.9M (down 36% from $58.0M in Q2 2025), billings of $65.5M (down 34%), and net loss of $(14.9)M (versus $(9.3)M prior year). Monthly qualified users fell 17% to 185.4M. The company divested its Bridg business in March 2026 for 1,810,222 PAR shares. Q3 2026 guidance projects billings of $61.0–$67.0M (down 20–27% YoY) and adjusted EBITDA of $0–$3.0M.
Why this rating
Large revenue decline (36% YoY) and widening losses material to $85.8M market cap; divestiture eliminates growth asset. Offsetting: core platform margins improving, guidance provided, cash position $28M. Deteriorating fundamentals but not imminent insolvency.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.